文献速递肺外科

肺叶切除术为I期肺癌高龄患者提供最佳生存获益

Lobectomy Provides the Best Survival for Stage I Lung Cancer Patients Despite Advanced Age.
PubMed 文献 · Ann Thorac Surg · 2022-03-26

基于美国国家癌症数据库2004至2016年病理I期肺癌八十岁以上患者数据,比较肺叶切除术与亚肺叶切除术(肺段或楔形切除)的5年生存率。肺叶切除组5年生存率48.5%,亚肺叶切除组41.1%(P < .001)。结论认为,无论手术年龄,肺叶切除均较亚肺叶切除提供更好的5年生存,若患者医学上能耐受手术,所有I期肺癌患者均应考虑肺叶切除术。

要点

  • 八十岁以上病理I期肺癌患者中,肺叶切除组5年生存率48.5%,亚肺叶切除组41.1%(P < .001)。
  • 立方样条图提示不存在亚肺叶切除生存优于或等于肺叶切除的年龄(P < .001)。
  • 作者认为,若患者医学上能耐受手术,所有I期肺癌患者均应考虑肺叶切除术。

核心结论

  • 在八十岁以上病理I期肺癌患者中,无论手术年龄,肺叶切除较亚肺叶切除提供更好的5年生存。
  • 作者认为,若患者医学上能耐受手术,所有I期肺癌患者均应考虑肺叶切除术。

研究设计与样本

  • 分析美国国家癌症数据库2004至2016年八十岁以上病理I期肺癌患者。
  • 比较接受肺叶切除或亚肺叶切除(肺段切除或楔形切除)患者的5年生存率,并采用立方样条图确定肺叶切除不提供生存优势的年龄切点。

主要发现

  • 八十岁以上患者共227 134例,其中病理I期肺癌25 362例(26%)。
  • 接受亚肺叶切除者6 370例(30%),包括肺段切除1 192例和楔形切除5 178例;接受肺叶切除者14 594例(70%)。
  • 肺叶切除组5年生存率48.5%,亚肺叶切除组41.1%,差异有统计学意义(P < .001)。
  • 立方样条图提示不存在亚肺叶切除生存优于或等于肺叶切除的年龄(P < .001)。

临床怎么用

  • 作者认为,对于医学上能耐受手术的I期肺癌患者,应考虑肺叶切除术。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Lung Cancer Study Group has shown that lobectomy provides the best survival in patients with non-small cell lung cancer. However, as patients become older, lobectomy may not provide a survival advantage compared with sublobar resection. METHODS: We analyzed the National Cancer Database for octogenarians with pathologic stage I lung cancer from 2004 to 2016. We then evaluated the patients who underwent lobectomy or sublobar (segmentectomy or wedge) resection for the treatment of cancer. We analyzed the 5-year survival rates of the groups as well as a cubic spline plot to determine age cutoffs where lobectomy does not provide improved survival. RESULTS: Among the octogenarians (227 134), there were 25 362 (26%) who had pathologic stage I lung cancer. There were 6370 (30%) patients who had sublobar resections (segmentectomy [n = 1192] and wedge resection [n = 5178]), whereas 14 594 (70%) patients had a lobectomy. There was significantly improved survival at 5 years with lobectomy compared with sublobar resection (48.5% vs 41.1%; P < .001). The cubic spline plot provided evidence that there was no age at which sublobar resection provided survival better than or equal to lobectomy (P < .001). CONCLUSIONS: In octogenarians with pathologic stage I lung cancer, lobectomy provided better 5-year survival compared with sublobar resection regardless of the age at surgical procedure. Hence, all patients with stage I cancer should be considered for a lobectomy if they are medically able to tolerate such a procedure.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Chan EY, Amirkhosravi F, Nguyen DT, et al. Lobectomy Provides the Best Survival for Stage I Lung Cancer Patients Despite Advanced Age. Ann Thorac Surg. 2022. PMID: 35351425. doi:10.1016/j.athoracsur.2022.03.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。